Skip to content

Automated artificial-intelligence based, preliminary cardiac diagnostics decision support tool to the medical practitioner.

A feasibility study to assess Artificial Intelligence (AI) algorithm performance in identifying heart murmurs in the general echocardiography referred patient’s population.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12619000366156
Enrollment
118
Registered
2019-03-07
Start date
2019-03-15
Completion date
2022-03-12
Last updated
2021-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

MedAl Cardiology is a software tool that will enable health care professionals to diagnose various heart conditions in real time using Artificial Intelligence (AI). It would provide a diagnosis of heart functioning by analysing heart sounds recordings. The MedAI Cardiology algorithm will classify the patient status as “Normal” or “Abnormal” and will provide in-depth insights about various heart conditions. An automated analysis capability will support medical practitioners in deciding whether or not to refer the patient for further investigation.

Interventions

Participants will be exposed to auscultation done with a digital stethoscope. The patient's heart sounds audio will be recorded and analysed remotely. An Echocardiography will follow, which is done as a part of the patient's routine investigation. We estimate that the auscultation will not add to the patient visit at the Echocardiography laboratory more than 5-10 minutes. An Echocardiograph which is done as part of the patient routine investigation and done in accordance to standard of care wil

Participants will be exposed to auscultation done with a digital stethoscope. The patient's heart sounds audio will be recorded and analysed remotely. An Echocardiography will follow, which is done as a part of the patient's routine investigation. We estimate that the auscultation will not add to the patient visit at the Echocardiography laboratory more than 5-10 minutes. An Echocardiograph which is done as part of the patient routine investigation and done in accordance to standard of care will follow and is estimated to take approximately 45 minutes. This will conclude the participant involvement in the trial. The gathered data would be used to train an Artificial-Intelligence system to identify valvular heart diseases based on auscultation.

Sponsors

Visionware Solutions Pty Ltd
Lead SponsorCommercial sector/Industry

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

o Patient over the age of 18 years old, who is able to provide written informed consent and verbal consent to participate in this study. o The patient is referred to perform an Echocardiography.

Exclusion criteria

o A patient who is unable to provide written and verbal informed consent. o A female patient who is aware she is pregnant.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026